Acadian Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Acadian Asset Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-120,658	Closed	-$936K	–	1863
2023 Q3	$936K	Buy	120,658 +399	+0.3%	+$2.16K	﹤0.01%	867
2023 Q2	$623K	Hold	120,259	–	–	﹤0.01%	997
2023 Q1	$645K	Sell	120,259 -1	-0%	-$5	﹤0.01%	990
2022 Q4	$445K	Buy	120,260 +10,401	+9%	+$46K	﹤0.01%	1070
2022 Q3	$549K	Buy	109,859 +83,691	+320%	+$466K	﹤0.01%	965
2022 Q2	$153K	Buy	+26,168	New	+$148K	﹤0.01%	1264
2022 Q1	–	Sell	-10,817	Closed	-$141K	–	1859
2021 Q4	$141K	Buy	+10,817	New	+$179K	﹤0.01%	1306

Other funds holding ORTX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Acadian Asset Management's ORTX Position: Q4 2023 in Review

Acadian Asset Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2023, closing a stake of 120,658 shares — an estimated $936K sold.

Acadian Asset Management first reported a position in ORTX in Q4 2021 and held it in 7 quarters. The position peaked at $936K in Q3 2023. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2023.

Acadian Asset Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Acadian Asset Management sold 120,658 Orchard Therapeutics plc American Depositary Shares shares in Q4 2023, an estimated $936K.
Acadian Asset Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and held it in 7 quarters.
Acadian Asset Management's Orchard Therapeutics plc American Depositary Shares position peaked at $936K in Q3 2023.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2023.

Based on Acadian Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.